IBDEI11P ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18731,1,3,0)
 ;;=3^96372
 ;;^UTILITY(U,$J,358.3,18732,0)
 ;;=20501^^122^1199^8^^^^1
 ;;^UTILITY(U,$J,358.3,18732,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18732,1,2,0)
 ;;=2^Injection of sinus tract;diagnostic
 ;;^UTILITY(U,$J,358.3,18732,1,3,0)
 ;;=3^20501
 ;;^UTILITY(U,$J,358.3,18733,0)
 ;;=J0690^^122^1200^1^^^^1
 ;;^UTILITY(U,$J,358.3,18733,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18733,1,2,0)
 ;;=2^Cefazolin Sodium Inj 500mg
 ;;^UTILITY(U,$J,358.3,18733,1,3,0)
 ;;=3^J0690
 ;;^UTILITY(U,$J,358.3,18734,0)
 ;;=S0077^^122^1200^2^^^^1
 ;;^UTILITY(U,$J,358.3,18734,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18734,1,2,0)
 ;;=2^Clindamycin Phosphate Inj 300mg
 ;;^UTILITY(U,$J,358.3,18734,1,3,0)
 ;;=3^S0077
 ;;^UTILITY(U,$J,358.3,18735,0)
 ;;=J3360^^122^1200^4^^^^1
 ;;^UTILITY(U,$J,358.3,18735,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18735,1,2,0)
 ;;=2^Diazepam up to 5mg
 ;;^UTILITY(U,$J,358.3,18735,1,3,0)
 ;;=3^J3360
 ;;^UTILITY(U,$J,358.3,18736,0)
 ;;=J1710^^122^1200^5^^^^1
 ;;^UTILITY(U,$J,358.3,18736,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18736,1,2,0)
 ;;=2^Hydrocortisone Sodium Phosphate Inj up to 50mg
 ;;^UTILITY(U,$J,358.3,18736,1,3,0)
 ;;=3^J1710
 ;;^UTILITY(U,$J,358.3,18737,0)
 ;;=J2550^^122^1200^7^^^^1
 ;;^UTILITY(U,$J,358.3,18737,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18737,1,2,0)
 ;;=2^Promethazinc HCL Inj up to 50mg
 ;;^UTILITY(U,$J,358.3,18737,1,3,0)
 ;;=3^J2550
 ;;^UTILITY(U,$J,358.3,18738,0)
 ;;=J3301^^122^1200^8^^^^1
 ;;^UTILITY(U,$J,358.3,18738,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18738,1,2,0)
 ;;=2^Triamcinolone Acetonide per 10mg
 ;;^UTILITY(U,$J,358.3,18738,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,18739,0)
 ;;=J3302^^122^1200^9^^^^1
 ;;^UTILITY(U,$J,358.3,18739,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18739,1,2,0)
 ;;=2^Triamcinolone Diacetate per 5mg
 ;;^UTILITY(U,$J,358.3,18739,1,3,0)
 ;;=3^J3302
 ;;^UTILITY(U,$J,358.3,18740,0)
 ;;=J3303^^122^1200^10^^^^1
 ;;^UTILITY(U,$J,358.3,18740,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18740,1,2,0)
 ;;=2^Triamcinolone Hexacetonide per 5mg
 ;;^UTILITY(U,$J,358.3,18740,1,3,0)
 ;;=3^J3303
 ;;^UTILITY(U,$J,358.3,18741,0)
 ;;=J3410^^122^1200^6^^^^1
 ;;^UTILITY(U,$J,358.3,18741,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18741,1,2,0)
 ;;=2^Hydroxyzine HCL up to 25mg
 ;;^UTILITY(U,$J,358.3,18741,1,3,0)
 ;;=3^J3410
 ;;^UTILITY(U,$J,358.3,18742,0)
 ;;=J1094^^122^1200^3^^^^1
 ;;^UTILITY(U,$J,358.3,18742,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18742,1,2,0)
 ;;=2^Dexamethasone, per mg
 ;;^UTILITY(U,$J,358.3,18742,1,3,0)
 ;;=3^J1094
 ;;^UTILITY(U,$J,358.3,18743,0)
 ;;=26535^^122^1201^1^^^^1
 ;;^UTILITY(U,$J,358.3,18743,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18743,1,2,0)
 ;;=2^Arthroplasty, interphalangeal joint; each joint
 ;;^UTILITY(U,$J,358.3,18743,1,3,0)
 ;;=3^26535
 ;;^UTILITY(U,$J,358.3,18744,0)
 ;;=26536^^122^1201^2^^^^1
 ;;^UTILITY(U,$J,358.3,18744,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18744,1,2,0)
 ;;=2^Arthroplasty, interphalangeal joint; with prosthetic implant, each jointangeal 
 ;;^UTILITY(U,$J,358.3,18744,1,3,0)
 ;;=3^26536
 ;;^UTILITY(U,$J,358.3,18745,0)
 ;;=27650^^122^1201^3^^^^1
 ;;^UTILITY(U,$J,358.3,18745,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18745,1,2,0)
 ;;=2^Repair, primary, open or percutaneous, ruptured Achilles tendon
 ;;^UTILITY(U,$J,358.3,18745,1,3,0)
 ;;=3^27650
 ;;^UTILITY(U,$J,358.3,18746,0)
 ;;=27686^^122^1201^5^^^^1
 ;;^UTILITY(U,$J,358.3,18746,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18746,1,2,0)
 ;;=2^Lengthening or shortening of tendon each, leg or ankle; multiple  tendon
